ID   HYPDH_HUMAN             Reviewed;         536 AA.
AC   Q9UF12;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 108.
DE   RecName: Full=Hydroxyproline dehydrogenase {ECO:0000303|PubMed:25697095};
DE            Short=HYPDH {ECO:0000303|PubMed:25697095};
DE            EC=1.5.5.- {ECO:0000269|PubMed:25697095};
DE   AltName: Full=Kidney and liver proline oxidase 1;
DE            Short=HsPOX1;
DE   AltName: Full=Probable proline dehydrogenase 2 {ECO:0000312|HGNC:HGNC:17325};
DE            EC=1.5.5.2 {ECO:0000269|PubMed:25697095};
DE   AltName: Full=Probable proline oxidase 2;
GN   Name=PRODH2 {ECO:0000312|HGNC:HGNC:17325};
GN   Synonyms=HSPOX1 {ECO:0000312|HGNC:HGNC:17325},
GN   HYPDH {ECO:0000303|PubMed:25697095};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Lin W.-W., Hu C.A., Valle D.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBSTRATE SPECIFICITY, AND ENZYME REGULATION.
RX   PubMed=25697095; DOI=10.1042/BJ20141159;
RA   Summitt C.B., Johnson L.C., Joensson T.J., Parsonage D., Holmes R.P.,
RA   Lowther W.T.;
RT   "Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase
RT   (HYPDH) and molecular target for treating primary hyperoxaluria.";
RL   Biochem. J. 466:273-281(2015).
CC   -!- FUNCTION: Dehydrogenase that converts trans-4-L-hydroxyproline to
CC       delta-1-pyrroline-3-hydroxy-5-carboxylate (Hyp) using ubiquinone-
CC       10 as the terminal electron acceptor. Can also use proline as a
CC       substrate but with a very much lower efficiency. Does not react
CC       with other diastereomers of Hyp: trans-4-D-hydroxyproline and cis-
CC       4-L-hydroxyproline. Ubiquininone analogs such as menadione,
CC       duroquinone and ubiquinone-1 react more efficiently than oxygen as
CC       the terminal electron acceptor during catalysis.
CC       {ECO:0000269|PubMed:25697095}.
CC   -!- CATALYTIC ACTIVITY: trans-4-hydroxy-L-proline + ubiquinone-10 =
CC       (3R,5S)-1-pyrroline-3-hydroxy-5-carboxylate + ubiquinol-10.
CC       {ECO:0000269|PubMed:25697095}.
CC   -!- CATALYTIC ACTIVITY: L-proline + a quinone = (S)-1-pyrroline-5-
CC       carboxylate + a quinol. {ECO:0000269|PubMed:25697095}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:25697095};
CC   -!- ENZYME REGULATION: Hydroproxyproline dehydrogenase activity is
CC       inhibited by THFA,(1R,3R)3-OH-cyclopentane-COOH and 5-OH-1H-
CC       pyrazole-3-COOH. {ECO:0000269|PubMed:25697095}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=200 mM for trans-4-L-hydroxyproline
CC         {ECO:0000269|PubMed:25697095};
CC         KM=28 mM for oxygen {ECO:0000269|PubMed:25697095};
CC         KM=143 uM for duroquinone {ECO:0000269|PubMed:25697095};
CC         KM=25 uM for menadione {ECO:0000269|PubMed:25697095};
CC         KM=124 uM for ubiquinone-1 {ECO:0000269|PubMed:25697095};
CC         Note=kcat with trans-4-L-hydroxyproline (Hyp) and ubiquinone-1
CC         is 0.19 sec(-1). Proline is unable to saturate PRODH2 at least
CC         up to 750mM. kcat/KM with proline and ubiquinone-10: 0.075 M(-
CC         1)/sec. kcat with oxygen, duroquinone, menadione and CoQ1 and
CC         with trans-4-L-hydroxyproline are 0.002 sec(-1), 0.27 sec(-1),
CC         0.28 sec(-1) and 0.19 sec(-1), respectively.
CC         {ECO:0000269|PubMed:25697095};
CC   -!- SIMILARITY: Belongs to the proline oxidase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U80018; AAF21465.1; -; mRNA.
DR   CCDS; CCDS12478.1; -.
DR   RefSeq; NP_067055.1; NM_021232.1.
DR   UniGene; Hs.515366; -.
DR   ProteinModelPortal; Q9UF12; -.
DR   SMR; Q9UF12; -.
DR   STRING; 9606.ENSP00000301175; -.
DR   iPTMnet; Q9UF12; -.
DR   BioMuta; PRODH2; -.
DR   DMDM; 74720632; -.
DR   MaxQB; Q9UF12; -.
DR   PaxDb; Q9UF12; -.
DR   PeptideAtlas; Q9UF12; -.
DR   PRIDE; Q9UF12; -.
DR   DNASU; 58510; -.
DR   Ensembl; ENST00000301175; ENSP00000301175; ENSG00000250799.
DR   GeneID; 58510; -.
DR   KEGG; hsa:58510; -.
DR   UCSC; uc002obx.1; human.
DR   CTD; 58510; -.
DR   DisGeNET; 58510; -.
DR   GeneCards; PRODH2; -.
DR   HGNC; HGNC:17325; PRODH2.
DR   HPA; HPA051287; -.
DR   MalaCards; PRODH2; -.
DR   MIM; 616377; gene.
DR   neXtProt; NX_Q9UF12; -.
DR   OpenTargets; ENSG00000250799; -.
DR   PharmGKB; PA33802; -.
DR   eggNOG; KOG0186; Eukaryota.
DR   eggNOG; COG0506; LUCA.
DR   GeneTree; ENSGT00390000006265; -.
DR   HOGENOM; HOG000233406; -.
DR   HOVERGEN; HBG108294; -.
DR   InParanoid; Q9UF12; -.
DR   KO; K11394; -.
DR   OMA; TGNILMQ; -.
DR   OrthoDB; EOG091G09N3; -.
DR   PhylomeDB; Q9UF12; -.
DR   TreeFam; TF313544; -.
DR   BioCyc; MetaCyc:MONOMER66-34410; -.
DR   GenomeRNAi; 58510; -.
DR   PRO; PR:Q9UF12; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000250799; -.
DR   CleanEx; HS_PRODH2; -.
DR   ExpressionAtlas; Q9UF12; baseline and differential.
DR   Genevisible; Q9UF12; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0071949; F:FAD binding; IBA:GO_Central.
DR   GO; GO:0004657; F:proline dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0010133; P:proline catabolic process to glutamate; IBA:GO_Central.
DR   Gene3D; 3.20.20.220; -; 1.
DR   InterPro; IPR029041; FAD-linked_oxidoreductase-like.
DR   InterPro; IPR002872; Proline_DH_dom.
DR   InterPro; IPR015659; Proline_oxidase.
DR   PANTHER; PTHR13914; PTHR13914; 1.
DR   Pfam; PF01619; Pro_dh; 1.
DR   SUPFAM; SSF51730; SSF51730; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; FAD; Flavoprotein; Oxidoreductase;
KW   Polymorphism; Proline metabolism; Reference proteome.
FT   CHAIN         1    536       Hydroxyproline dehydrogenase.
FT                                /FTId=PRO_0000308623.
FT   MOD_RES     386    386       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VCZ9}.
FT   VARIANT      91     91       P -> R (in dbSNP:rs3848666).
FT                                /FTId=VAR_036852.
FT   VARIANT     525    525       R -> Q (in dbSNP:rs3761097).
FT                                /FTId=VAR_036853.
SQ   SEQUENCE   536 AA;  58871 MW;  81EB2F4B21E39E09 CRC64;
     MSPRVVSNSS VLASQSVGIT NVRTVFSNVF NNTTAFPILR GSNCHKITAP GLGKGQLVNL
     LPPENLPWCG GSQGPRMLRT CYVLCSQAGP PSRGWQSLSF DGGAFHLKGT GELTRALLVL
     RLCAWPPLVT HGLLLQAWSR RLLGSRLSGA FLRASVYGQF VAGETAEEVK GCVQQLRTLS
     LRPLLAVPTE EEPDSAAKSG EAWYEGNLGA MLRCVDLSRG LLEPPSLAEA SLMQLKVTAL
     TSTRLCKELA SWVRRPGASL ELSPERLAEA MDSGQNLQVS CLNAEQNQHL RASLSRLHRV
     AQYARAQHVR LLVDAEYTSL NPALSLLVAA LAVRWNSPGE GGPWVWNTYQ ACLKDTFERL
     GRDAEAAHRA GLAFGVKLVR GAYLDKERAV AQLHGMEDPT QPDYEATSQS YSRCLELMLT
     HVARHGPMCH LMVASHNEES VRQATKRMWE LGIPLDGTVC FGQLLGMCDH VSLALGQAGY
     VVYKSIPYGS LEEVIPYLIR RAQENRSVLQ GARREQELLS QELWRRLLPG CRRIPH
//
